Cutera (CUTR) Set to Announce Earnings on Thursday

Cutera (NASDAQ:CUTR) is set to post its quarterly earnings results after the market closes on Thursday, August 8th. Analysts expect Cutera to post earnings of ($0.90) per share for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.

Cutera (NASDAQ:CUTR) last posted its quarterly earnings data on Thursday, May 9th. The medical device company reported ($1.14) EPS for the quarter, missing the consensus estimate of ($1.09) by ($0.05). The company had revenue of $38.79 million for the quarter, compared to analysts’ expectations of $37.17 million. During the same period in the previous year, the business posted ($1.26) EPS. On average, analysts expect Cutera to post $-6 EPS for the current fiscal year and $-4 EPS for the next fiscal year.

Cutera Stock Up 4.6 %

NASDAQ CUTR opened at $1.13 on Wednesday. The firm has a market cap of $22.71 million, a PE ratio of -0.16 and a beta of 1.32. The company has a 50 day moving average price of $1.59 and a 200 day moving average price of $2.01. Cutera has a 52 week low of $1.05 and a 52 week high of $18.83.

Analyst Upgrades and Downgrades

CUTR has been the topic of a number of recent analyst reports. Piper Sandler restated a “neutral” rating and set a $3.00 price target on shares of Cutera in a research note on Friday, June 21st. StockNews.com raised shares of Cutera to a “sell” rating in a report on Friday, May 10th. Finally, Stephens reissued an “overweight” rating and set a $10.00 price target on shares of Cutera in a report on Tuesday, June 25th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $7.67.

Insider Activity

In other news, EVP Michael Karavitis sold 10,848 shares of the stock in a transaction dated Tuesday, May 14th. The shares were sold at an average price of $2.45, for a total value of $26,577.60. Following the completion of the sale, the executive vice president now directly owns 52,755 shares in the company, valued at $129,249.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.42% of the company’s stock.

Cutera Company Profile

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truFlex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; and excel V+, a vascular and benign pigmented lesion treatment platform.